Tag: Organ Transplants
FDA Approves Livtencity for Posttransplant Cytomegalovirus
Livtencity is indicated for posttransplant CMV that does not respond to available antiviral treatments
Number of Elderly on U.S. Liver Transplant List Rising
Outcomes for elderly patients receiving liver transplants also improving
Liver Transplant Outcomes Worse for Nonoverweight NAFLD Patients
Outcomes worse before and after liver transplant for nonoverweight versus overweight/obese adults with nonalcoholic fatty liver disease
Impact of 2014 Policy Change Examined for Pediatric Kidney Transplants
Racial/ethnic disparities in time from dialysis initiation to transplantation mitigated by 2014 Kidney Allocation System
Doctors Report That Kidney Grown in Pig Worked in a Human
Kidney came from pig genetically engineered to grow an organ with a low risk for being rejected by the human body
Cancer Linked to Shortened Life Span for Solid Organ Recipients
Overall, cancer responsible for loss of 1.9 percent of total life years expected in the absence of cancer in transplant recipients
Survival Rates Lower for Black Liver Transplant Recipients
For Blacks versus Whites, differences in post-LT mortality narrowed between 2002 and 2009, increased between 2014 and 2018
Donor HLA Evolutionary Divergence May Predict Liver Transplant Rejection
Class I HED of the donor is associated with higher risk for acute and chronic rejection of the liver transplant
COVID-19 Mortality Lower for Vaccinated Solid Organ Transplant Recipients
Second study shows increased risk for breakthrough COVID-19 infection and associated mortality for SOTRs versus general population
Third Dose of mRNA-1273 Boosts Immunity in Transplant Recipients
More patients receiving mRNA-1273 booster have serologic response with anti-receptor-binding domain antibody level of at least 100 U/mL
